Seker, U. Et Al. 2022. Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways. Andrologia , vol.54, no.11 .

Seker, U., Kavak, D. E., Guzel, B. C., Baygeldi, S. B., YÜKSEL, M., Unay Demirel, O., ... Irtegun Kandemir, S.(2022). Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways. Andrologia , vol.54, no.11.

Seker, Ugur Et Al. "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways," Andrologia , vol.54, no.11, 2022

Seker, Ugur Et Al. "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways." Andrologia , vol.54, no.11, 2022

Seker, U. Et Al. (2022) . "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways." Andrologia , vol.54, no.11.

@article{article, author={Ugur Seker Et Al. }, title={Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways}, journal={Andrologia}, year=2022}